Most Read Articles
Pearl Toh, 31 Dec 2019
Adding the neuraminidase inhibitor oseltamivir to usual care speeds up recovery from influenza-like illness by a day compared with usual care alone, with even greater benefits seen in older, sicker patients with comorbidities, according to the ALIC4E study.
23 Dec 2019
At a Menarini-sponsored symposium held during the Asian Pacific Society Congress, renowned cardiologist Prof John Camm provided the latest evidence for chronic stable angina with or without concomitant diseases, with a special focus on the antianginal agent ranolazine and combination therapies. The event was chaired and moderated by Dr Dante Morales from the University of the Philippines College of Medicine.
Pearl Toh, 5 days ago
Obeticholic acid significantly improves fibrosis and disease activity in patients with nonalcoholic steatohepatitis (NASH), a chronic liver disease currently with no approved therapy, according to an interim analysis of the landmark REGENERATE* study.
6 days ago
Testosterone treatment may slightly improve sexual functioning and quality of life in men without underlying organic causes of hypogonadism, but it offers little to no benefit for other common symptoms of ageing, according to a study. In addition, long-term efficacy and safety of this therapy remain unknown.

Seaweed intake may reduce risk of ischaemic heart disease

27 Dec 2019
Seaweed that was only previously known to play a part in sushi rolls, has gained tremendous popularity on the health scale.

Eating seaweeds appears to confer a protective benefit against the development of ischaemic heart disease, suggests a Japan study.

The investigators identified 4,777 strokes (2,863 ischaemic stroke, 1,361 intraparenchymal haemorrhages and 531 subarachnoid haemorrhages) and 1,204 ischaemic heart disease cases during 1,493,232 person-years of follow-up.

Almost daily consumption compared with almost no consumption of seaweed among men was inversely associated with risk of ischaemic heart disease (hazard ratio [HR], 0.76, 95 percent confidence interval [CI], 0.58–0.99; p-trend=0.04) and total cardiovascular diseases (HR, 0.88, 95 percent CI, 0.78–1.00; p-trend=0.08). Such inverse associations were also seen among women for ischaemic heart disease (HR, 0.56, 95 percent CI, 0.36–0.85; p-trend=0.006) and total cardiovascular diseases (HR, 0.89, 95 percent CI, 0.76–1.05; p-trend=0.10).

Significant observations were not observed between intake and risk of total stroke or stroke types among either men or women.

This study surveyed 40,707 men and 45,406 women from two large cohorts (age range, 40–69 years). A food frequency questionnaire was used to determine seaweed consumption at baseline (1990–1994). Incidences of stroke were ascertained until the end of 2009 (cohort I) or 2012 (cohort II). Cox proportional hazard models were used to estimate sex-specific cardiovascular disease HRs after stratification by area and adjustment for cardiovascular disease risk and dietary factors.

“The minerals, vitamins, soluble dietary fibres and flavonoids of seaweed are protective for preventing cardiovascular diseases,” the investigators noted.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Pearl Toh, 31 Dec 2019
Adding the neuraminidase inhibitor oseltamivir to usual care speeds up recovery from influenza-like illness by a day compared with usual care alone, with even greater benefits seen in older, sicker patients with comorbidities, according to the ALIC4E study.
23 Dec 2019
At a Menarini-sponsored symposium held during the Asian Pacific Society Congress, renowned cardiologist Prof John Camm provided the latest evidence for chronic stable angina with or without concomitant diseases, with a special focus on the antianginal agent ranolazine and combination therapies. The event was chaired and moderated by Dr Dante Morales from the University of the Philippines College of Medicine.
Pearl Toh, 5 days ago
Obeticholic acid significantly improves fibrosis and disease activity in patients with nonalcoholic steatohepatitis (NASH), a chronic liver disease currently with no approved therapy, according to an interim analysis of the landmark REGENERATE* study.
6 days ago
Testosterone treatment may slightly improve sexual functioning and quality of life in men without underlying organic causes of hypogonadism, but it offers little to no benefit for other common symptoms of ageing, according to a study. In addition, long-term efficacy and safety of this therapy remain unknown.